All One Health Content – Page 138
-
NewsPrior exposure to common virus shields against birth defects and miscarriage
A new study uncovers how pre-existing immunity to Cytomegalovirus (CMV) may significantly reduce the risk of birth defects and miscarriage during pregnancy, offering hope for a future vaccine.
-
NewsVulnerability to different COVID-19 mutations depends on previous infections and vaccination
A person’s immune response to variants of SARS-CoV-2 depends on their previous exposure – and differences in the focus of immune responses will help scientists understand how to optimise vaccines in the future to provide broad protection.
-
NewsNasal vaccine could be the new line of defence against Strep A
As Streptococcus A cases continue to be prevalent in Queensland and internationally, a new nasal vaccine could provide long-term protection from the deadly bacteria.
-
NewsWastewater surveillance research provides 12-day lead time for RSV season
Researchers using wastewater surveillance over conventional indicators have predicted the start of the annual respiratory syncytial virus (RSV) season 12 days early, providing more lead time for hospital preparedness.
-
NewsStudy IDs six drugs that can be repurposed for treatment of toxoplasmosis
Brazilian researchers screened 160 compounds known to be effective against SARS-CoV-2 and identified those that also act against the protozoan parasite Toxoplasma gondii.
-
NewsCovid-19 protein primes RNA synthesis in human cells
Researchers have shown for the first time that it is the human protein SND1 which works together with the viral protein NSP9 to stimulate the SARS-CoV-2 virus’s genetic replication program in infected cells.
-
NewsSingle vaccine shot could thwart eight hospital superbugs
A single dose of an experimental vaccine, administered in mouse models, can provide rapid protection against eight different bacteria and fungi species.
-
NewsSugar binding to spike protein is key to coronavirus cell entry
A study uses powerful microscopes and computer simulations to reveal how a tiny sugar molecule binds to a human coronavirus spike and triggers exposure of components that are required to invade the host cell.
-
NewsPortable laboratory devices can detect SARS-CoV-2
A new study has demonstrated rapid and sensitive on-site detection of SARS-CoV-2 RNA from environmental surfaces using a portable laboratory device.
-
NewsResearchers receive international funding to study spiderwebs as biosensors
The dew-covered spiderweb you see in your yard might soon become a platform to detect airborne viruses, according to Jiangtao Cheng, who hopes to build bio-inspired technology that could serve as an early warning system for pathogens.
-
NewsResearchers developing an oral therapeutic to treat drug-resistant bacterial pneumonia
Australian researchers aim to rescue common antibiotics with a new therapeutic approach, using a drug originally developed to treat neurodegenerative disorders.
-
NewsScientists discover alternative base modification for mRNA therapeutics
Researchers have incorporated a newly discovered base, called base Z, into mRNA to create Z-mRNA that has improved translational capacity, decreased cytotoxicity and drastically reduced immunogenicity compared to unmodified mRNA.
-
NewsNew recommendation on meningitis vaccines for infants in sub-Saharan Africa
An IDCRC study assessing the meningococcal pentavalent (five in one) vaccine for infants in Africa shows vaccine provides protection against meningococcal meningitis.
-
NewsScientists track the bacteria behind life-threatening sepsis in premature babies
Researchers who teamed up with two Neonatal Intensive Care Units (NICUs) have found that transmission of sepsis-causing Staphylococcus strains between babies within NICUs was likely.
-
NewsResearcher awarded $1.9m to develop model to test phages in the gut
Bryan Hsu, an assistant professor of biological sciences at Virginia Tech, has received a five-year $1.9 million award to develop a model to test the role of lytic bacteriophages, or phages as they are commonly called, in the mammalian gut.
-
NewsOral lipid nanoparticle drug can prevent development of colitis-associated cancer
An oral lipid nanoparticle drug prevents tumor development in mice, suggesting this is a promising drug formulation for preventing colitis-associated cancer, according to a study led by researchers in the Institute for Biomedical Sciences at Georgia State University. The findings published in the journal Pharmaceutics report the ...
-
NewsInstitut Pasteur and University of Tokyo to form Planetary Health Innovation Center
The Institut Pasteur and the University of Tokyo have signed a letter of intent (LOI) to establish the Planetary Health Innovation Center (PHIC), marking the first step towards the Institut Pasteur of Japan, a private not-for-profit association.
-
NewsWastewater reveals signs of antimicrobial resistance in aged care
A new study analysing wastewater samples from several aged care and retirement homes in Adelaide, has uncovered worrying signs of antimicrobial resistance (AMR) in at least one facility.
-
NewsDoes COVID-19 or COVID-19 vaccination worsen migraines?
New research indicates that COVID-19 and COVID-19 vaccination have negligible effects on migraine severity.
-
NewsResearcher’s work on silent flagellins earns major award
Sara Clasen, a postdoctoral fellow in the Institute for Biomedical Sciences at Georgia State University, is the grand prize winner of the prestigious 2023 NOSTER & Science Microbiome Prize.